V

VerImmune

9 employees

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$2.5M

from 3 investors over 3 rounds

V

VerImmune raised $2.5M on July 27, 2022

Investors: Mana Ventures, SeedFolio and Ulu Ventures

FAQ